Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2025-12-29 @ 12:01 AM
Study NCT ID:
NCT01581593
Status:
COMPLETED
Last Update Posted:
2021-02-16
First Post:
2012-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
Sponsor:
Kedrion S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2014-08-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-16
First Submit QC Date:
None
Study First Post Date:
2012-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-15
Results First Submit QC Date:
None
Results First Post Date:
2021-02-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-29
Last Update Post Date:
2021-02-16
Last Update Post Date Type:
ACTUAL